Nova Eye Medical (EYE) Discussion, page-1241

Yeah and to think that those 200 doctors alone were generating like $15m each year. There’s an absolute goldmine here with this much larger market the company now has access to thanks to the new device, won’t take much to record some pretty massive numbers.

Completely agree about 2RT as well. It's easy to forget about 2RT and the rest of the R&D with all the success of iTrack Advance in the foreground. Anti-VEGF drugs for advanced wet AMD were hailed as one of the most important breakthroughs in ophthalmology when first released, not to mention as well they’re in the top 5 drugs globally ranked by sales, so it would make sense that 2RT would be even more significant given it prevents progression to that stage in the first place - a much bigger market. Looking forward to seeing how things progress on that front as well, a partnership announcement would send this soaring I'm sure.